Mark S. Leventhal, Director at ProPhase Labs, Inc. (PRPH), bought 10,000 shares at $1.60 ($16K) on 2013-05-09, disclosed to the SEC on 2013-05-10.
Open-market purchase of $16k PRPH by Director. Below the thresholds we flag for high-conviction alerts (no C-suite role, rare reversal, cluster, or A-grade history).
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $1.60 | 8,696 | $14K | 87.0% |
| 2 | $1.60 | 1,304 | $2K | 13.0% |
| Total | $1.60 avg | 10,000 | $16K | 100% |
| Filing → |
| PRPH | BUY | 2012-11-30 | $231K | — | Filing → |